![Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation | Schizophrenia Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation | Schizophrenia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41537-020-00127-y/MediaObjects/41537_2020_127_Fig1_HTML.png)
Efficacy and safety of once-monthly Risperidone ISM® in schizophrenic patients with an acute exacerbation | Schizophrenia
![Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison | American Journal of Psychiatry Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison | American Journal of Psychiatry](https://ajp.psychiatryonline.org/cms/10.1176/ajp.2007.164.7.1050/asset/images/medium/r915f1.jpeg)
Efficacy and Tolerability of Olanzapine, Quetiapine, and Risperidone in the Treatment of Early Psychosis: A Randomized, Double-Blind 52-Week Comparison | American Journal of Psychiatry
![Weight Gain Associated With Olanzapine and Risperidone in Adolescent Patients: A Comparative Prospective Study - Journal of the American Academy of Child & Adolescent Psychiatry Weight Gain Associated With Olanzapine and Risperidone in Adolescent Patients: A Comparative Prospective Study - Journal of the American Academy of Child & Adolescent Psychiatry](https://www.jaacap.org/cms/attachment/31c0d5e7-5690-4770-b44d-73d96fb192a0/gr1.gif)
Weight Gain Associated With Olanzapine and Risperidone in Adolescent Patients: A Comparative Prospective Study - Journal of the American Academy of Child & Adolescent Psychiatry
![Review of the Safety of Second-Generation Antipsychotics: Are They Really "Atypically" Safe for Youth and Adults? | Psychiatrist.com Review of the Safety of Second-Generation Antipsychotics: Are They Really "Atypically" Safe for Youth and Adults? | Psychiatrist.com](https://www.psychiatrist.com/PublishingImages/11r01298t1.gif)
Review of the Safety of Second-Generation Antipsychotics: Are They Really "Atypically" Safe for Youth and Adults? | Psychiatrist.com
![Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports | BMC Medicine | Full Text Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports | BMC Medicine | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12916-021-02062-w/MediaObjects/12916_2021_2062_Fig1_HTML.png)
Benefits and harms of Risperidone and Paliperidone for treatment of patients with schizophrenia or bipolar disorder: a meta-analysis involving individual participant data and clinical study reports | BMC Medicine | Full Text
![Amisulpride vs. Risperidone in Chronic Schizophrenia: Results of a 6-month Double-blind Study | Neuropsychopharmacology Amisulpride vs. Risperidone in Chronic Schizophrenia: Results of a 6-month Double-blind Study | Neuropsychopharmacology](https://media.springernature.com/full/springer-static/image/art%3A10.1016%2FS0893-133X%2802%2900375-5/MediaObjects/41386_2002_Article_BF1395965_Fig1_HTML.jpg)
Amisulpride vs. Risperidone in Chronic Schizophrenia: Results of a 6-month Double-blind Study | Neuropsychopharmacology
![Long-Acting Injectable Risperidone: An Emerging Tool in Schizophrenia Treatment | Journal of Psychosocial Nursing and Mental Health Services Long-Acting Injectable Risperidone: An Emerging Tool in Schizophrenia Treatment | Journal of Psychosocial Nursing and Mental Health Services](https://journals.healio.com/cms/asset/b4fec65e-586a-4560-ac16-3281762911a2/10.3928_02793695-20051201-04-table2.jpg)